TrialClinical obesity2018

Improvements in health-related quality of life over 3 years with liraglutide 3.0 mg compared with placebo in participants with overweight or obesity.

R L Kolotkin et al.PubMed ↗Full text ↗Publisher ↗

A later paper about NCT01272219. The trial’s primary report, PMID 26132939, speaks for it on the map; the numbers here are shown and do not vote.

No numbers read from the abstract.